Mutual Fund Insights: BlackRock Health Sciences Ops Svc Fund (SHISX)

In-depth Analysis of BlackRock Health Sciences Ops Svc Fund (SHISX)

3 months 6 months 1 year 3 year 5 year

See BlackRock Health Sciences Ops Svc Fund (SHISX) performance details as of February 28, 2010

  

Last Trade: $29.51 on 3/19/2010, Change: +0.01 (0.03%)

  

Fund Manager - Erin P. Xie

Fund Manager Tenure: 6.6 years   [Similar Funds: SHSSX ]
Fundmojo Fund Grade: A (Score: 0.73)     (What does this score mean?)

Erin P. Xie is the managing director and Portfolio Manager of BlackRock Advisor.Before becoming part of BlackRock Advisors in 2005, Erin P. Xie was with State Street Research & Management since 2001. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.  Get more insights on Erin P. Xie

  

 What we like about BlackRock Health Sciences Ops Svc Fund (SHISX)

Data for BlackRock Health Sciences Ops Svc Fund (SHISX) as of February 28, 2010

• BlackRock Health Sciences Ops Svc Fund (SHISX) management has been with BlackRock Health Sciences Ops Svc Fund for 6.6 years
• BlackRock Health Sciences Ops Svc Fund (SHISX) has good short-term performance (1-year return 43.07% vs 40.03 % Health category average)
• BlackRock Health Sciences Ops Svc Fund (SHISX) has good mid-term performance (3-year return 7.55% vs 0.87 % Health category average)
• BlackRock Health Sciences Ops Svc Fund (SHISX) has a Morningstar rating of 4 and above
• BlackRock Health Sciences Ops Svc Fund (SHISX) has an annual stock turnover rate of 153.00% vs Health average of 169.11%. It is good that BlackRock Health Sciences Ops Svc management does not trade extensively for its return.
• BlackRock Health Sciences Ops Svc Fund (SHISX) is less volatile than its peers as it has a 3-year Standard Deviation of 15.61, lower than category average of 18.82
• BlackRock Health Sciences Ops Svc Fund (SHISX) has a lower management fee than its Health average: 1.35% vs 1.98%

  

 What we are cautious about BlackRock Health Sciences Ops Svc Fund (SHISX)

Data for BlackRock Health Sciences Ops Svc Fund (SHISX) as of February 28, 2010

• BlackRock Health Sciences Ops Svc Fund is a focused fund with 31.44% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
• BlackRock Health Sciences Ops Svc Fund (SHISX) has a less-than-ideal Long-term performance (5-year return 10.95% vs 4.77 % Health category average)
• BlackRock Health Sciences Ops Svc Fund (SHISX) ratio of up-years vs down years can be improved
• Even though BlackRock Health Sciences Ops Svc Fund carries no load, it does have a 0.25% of 12b1 promotion, distributions, marketing expenses

See BlackRock Health Sciences Ops Svc Fund (SHISX) performance details as of February 28, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

• Fidelity Select Pharmaceuticals (FPHAX)    [ Compare with BlackRock Health Sciences Ops Svc Fund (SHISX) ]
• See top fund managers for Health Category Funds
• Browse other funds in Health Category

  

BlackRock Health Sciences Ops Svc Fund (SHISX) Net Asset

Track net asset change of BlackRock Health Sciences Ops Svc fund (SHISX)

Date	Net Asset
02/2010	$1.19B
01/2010	$10.22M
11/2009	$8.75M

More historic net asset information on BlackRock Health Sciences Ops Svc Fund (SHISX)

  

BlackRock Health Sciences Ops Svc Fund (SHISX) Portfolio Allocation

Track portfolio allocation change of BlackRock Health Sciences Ops Svc fund (SHISX)

Date	Cash	Stock	Bond	Other
09/2009	1.49%	98.51%	0%	0%
06/2009	6.7%	93.3%	0%	0%
03/2009	0.19%	98.87%	0%	0.94%

Click here to see more historic asset allocation information on BlackRock Health Sciences Ops Svc Fund (SHISX)

  

Most Recent Top 10 Holdings in BlackRock Health Sciences Ops Svc Fund (SHISX)

Discover what BlackRock Health Sciences Ops Svc Fund (SHISX) manager is buying

30-Sep-09 ALCON INC [4.2%] PFIZER INC [3.75%] Roche Holding AG [3.14%] Amgen Inc. [2.98%] JOHNSON AND JOHNS DC [2.72%] BRISTOL-MYERS SQUIBB [2.66%] Novartis [2.54%] ABBOTT LABORATORIES [2.51%] MEDCOHEALTH SOLUTNS [2.47%] COVIDIEN PLC [2.39%]

30-Jun-09 Blackrock Liquidity Funds Tempfund Portfolio [6.7%] WYETH [6.27%] CVS CAREMARK CP [3.95%] WELLPOINT INC. [3.93%] ALCON INC [3.37%] PFIZER INC [3.14%] Amgen Inc. [2.77%] MEDCOHEALTH SOLUTNS [2.71%] Roche Holding AG [2.54%] BECTON DICKINSON CO [2.5%]

31-Mar-09 WYETH [6.68%] Amgen Inc. [5.82%] MEDCOHEALTH SOLUTNS [4.41%] Gilead Sciences, Inc. [4.22%] BECTON DICKINSON CO [4.08%] ABBOTT LABORATORIES [3.98%] CVS CAREMARK CP [3.83%] JOHNSON AND JOHNS DC [3.48%] PFIZER INC [3.2%] ALCON INC [2.94%]

Click here for Stock Holding Change Map in BlackRock Health Sciences Ops Svc Fund (SHISX)

  

Related books and products to BlackRock Health Sciences Ops Svc Fund (SHISX)

  

Latest News on BlackRock Health Sciences Ops Svc (SHISX)

See what is happening with BlackRock Health Sciences Ops Svc Fund (SHISX)

Yahoo! Finance: RSS feed not found See more news on BlackRock Health Sciences Ops Svc Fund (SHISX)

 

Books and Resources

 

 

See more information on BlackRock Health Sciences Ops Svc Fund (SHISX)

• BlackRock Health Sciences Ops Svc Fund Insights
• BlackRock Health Sciences Ops Svc Fund Performance Data
• BlackRock Health Sciences Ops Svc Fund News
• BlackRock Health Sciences Ops Svc Fund Score Explaination
• BlackRock Health Sciences Ops Svc Fund Manager Information
• Historic BlackRock Health Sciences Ops Svc Fund Asset Allocation Report
• Historic BlackRock Health Sciences Ops Svc Fund Top 10 Holding Tracking
• Historic BlackRock Health Sciences Ops Svc Fund Asset Under Management Tracking